AU477231B2 - New 2, 4, 5-trisubstituted oxazoles - Google Patents

New 2, 4, 5-trisubstituted oxazoles

Info

Publication number
AU477231B2
AU477231B2 AU56982/73A AU5698273A AU477231B2 AU 477231 B2 AU477231 B2 AU 477231B2 AU 56982/73 A AU56982/73 A AU 56982/73A AU 5698273 A AU5698273 A AU 5698273A AU 477231 B2 AU477231 B2 AU 477231B2
Authority
AU
Australia
Prior art keywords
new
oxazoles
trisubstituted
trisubstituted oxazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU56982/73A
Other languages
English (en)
Other versions
AU5698273A (en
Inventor
Tarzia Giorgio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Publication of AU5698273A publication Critical patent/AU5698273A/en
Application granted granted Critical
Publication of AU477231B2 publication Critical patent/AU477231B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU56982/73A 1972-08-07 1973-06-15 New 2, 4, 5-trisubstituted oxazoles Expired AU477231B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2795872 1972-08-07

Publications (2)

Publication Number Publication Date
AU5698273A AU5698273A (en) 1974-12-19
AU477231B2 true AU477231B2 (en) 1976-10-21

Family

ID=11222675

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56982/73A Expired AU477231B2 (en) 1972-08-07 1973-06-15 New 2, 4, 5-trisubstituted oxazoles

Country Status (23)

Country Link
JP (1) JPS5030619B2 (fr)
KR (1) KR780000069B1 (fr)
AR (1) AR200007A1 (fr)
AT (1) AT322551B (fr)
AU (1) AU477231B2 (fr)
BE (1) BE794096A (fr)
CH (1) CH544105A (fr)
CS (1) CS177127B2 (fr)
DD (1) DD106387A5 (fr)
DE (1) DE2301030A1 (fr)
ES (1) ES417638A1 (fr)
FR (1) FR2195430B1 (fr)
GB (1) GB1374345A (fr)
HU (1) HU164781B (fr)
IE (1) IE36941B1 (fr)
IL (1) IL40904A (fr)
LU (1) LU66643A1 (fr)
NL (1) NL149797B (fr)
NO (1) NO137550C (fr)
RO (1) RO63442A (fr)
SE (1) SE376236B (fr)
SU (1) SU511003A3 (fr)
ZA (1) ZA728259B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD112905A5 (fr) * 1971-09-02 1975-05-12 Snam Progetti
US4110256A (en) * 1976-06-22 1978-08-29 Nippon Soken, Inc. Catalyst for reforming fuel and method for producing same
JPS59125900U (ja) * 1983-02-10 1984-08-24 マルヤス機械株式会社 組立ライン装置
DE3425118A1 (de) * 1984-07-07 1986-01-16 Boehringer Mannheim Gmbh, 6800 Mannheim Neue redox-indikatoren
JPS6133499U (ja) * 1984-07-30 1986-02-28 中西金属工業株式会社 電気製品製造用パレツト
ES2245660T3 (es) * 1990-11-30 2006-01-16 Otsuka Pharmaceutical Co., Ltd. Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos.
GB0709031D0 (en) 2007-05-10 2007-06-20 Sareum Ltd Pharmaceutical compounds
WO2010111059A1 (fr) 2009-03-23 2010-09-30 Merck Sharp & Dohme Corp. Antagonistes du récepteur p2x3 pour le traitement de la douleur
GB201202027D0 (en) 2012-02-06 2012-03-21 Sareum Ltd Pharmaceutical compounds
US20130231340A1 (en) 2012-03-02 2013-09-05 Sareum Limited Pharmaceutical compounds
GB201617871D0 (en) 2016-10-21 2016-12-07 Sareum Limited Pharmaceutical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1226548A (fr) * 1967-06-14 1971-03-31 Wyeth John & Brother Ltd

Also Published As

Publication number Publication date
HU164781B (fr) 1974-04-11
NL7300326A (fr) 1974-02-11
CH544105A (fr) 1973-11-15
BE794096A (fr) 1973-05-16
AU5698273A (en) 1974-12-19
KR780000069B1 (en) 1978-03-30
IE36941B1 (en) 1977-03-30
JPS4945067A (fr) 1974-04-27
NO137550C (no) 1978-03-15
AR200007A1 (es) 1974-10-15
ES417638A1 (es) 1976-02-01
FR2195430A1 (fr) 1974-03-08
DD106387A5 (fr) 1974-06-12
NO137550B (no) 1977-12-05
FR2195430B1 (fr) 1976-04-09
CS177127B2 (fr) 1977-07-29
SE376236B (fr) 1975-05-12
AT322551B (de) 1975-05-26
DE2301030A1 (de) 1974-02-28
JPS5030619B2 (fr) 1975-10-02
NL149797B (nl) 1976-06-15
SU511003A3 (ru) 1976-04-15
RO63442A (fr) 1978-07-15
GB1374345A (en) 1974-11-20
IL40904A0 (en) 1973-01-30
IL40904A (en) 1975-12-31
ZA728259B (en) 1973-07-25
IE36941L (en) 1974-02-07
LU66643A1 (fr) 1973-02-14

Similar Documents

Publication Publication Date Title
CA1011741A (en) 5,6,7,8-tetrahydroquinoline-8-thiocarboxamides and related compounds
CA1012534A (en) 2,6-diaminonebularine derivatives
AU477231B2 (en) New 2, 4, 5-trisubstituted oxazoles
AU466924B2 (en) 2, 4, 5-trisubstituted oxazoles
CA993452A (en) 2,6-dihalo-4-cyanophenoxy-acetonitriles
CA1009666A (en) 2,5,5-trimethyl-hepta-2,6-dienal
CA1020953A (fr) 2,2,3-endo-trimethyl-7-anti-amino-norbornanes
CA995222A (en) 1,2,4-oxadiazole derivatives
AU472337B2 (en) 11, 12-secoprostaglandins
CA999595A (en) 3,5-dialkyl-4-hydroxybenzyl-oxiranes and -thiiranes
AU467306B2 (en) 15, 16-methylene-4-oestren-17 -ols
AU474523B2 (en) Substituted 9,10-dihydroanthracenes
AU469505B2 (en) 1,4-ethano-2,3-dihydroquinoline derivatives
CA990280A (en) 5,6-trans-25-hydroxycholecalciferol
CA987669A (en) 10,11-anhydroerythromycins
CA986936A (en) 2,3,5-substituted-6-trifluoromethyl-1,3-diazin-4-ones
AU5701673A (en) 3, 4-dialkanyloxyphenyl)-l-alanines
CA902063A (en) 1,2,8,9-tetraazaphenalene-3-hydrazones
CA895310A (en) 1,2,4-triazine-5-ones
CA917160A (en) 1,4-oxathiins
CA906006A (en) 2,4-dihalo-3,5-dinitrobenzotrifluorides
CA914198A (en) 1,4-disubstituted-cyclohex-3-enes
CA905931A (en) 3,4-diazapregnanes
AU477691B2 (en) 2, 4, 5-trisubstituted-imidazoles
AU485879B2 (en) 3-diazine-substituted 1, 2, 4-benzothiadiazines